Scholarly Index
Jung‐Min Lee
Korea Pharma (South Korea); 2,195 total citations; 95 total publications; best world rank #466
Korea Pharma (South Korea)
2,195Total citations
95Total publications
19H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 949 | KR 12 | 91.08 |
| Health and Wellbeing Research | 2021-2025 | 466 | KR 207 | 76.54 |
| Education and Learning Interventions | 2021-2025 | 989 | KR 589 | 65.22 |
| Healthcare Education and Workforce Issues | 2021-2025 | 925 | KR 512 | 49.50 |